TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
KEY SERVICES
Reset all filters
01 1TAPI Technology & API Services
Reset all filters
01 1IMATINIB MESYLATE FORM ALPHA
Reset all filters
01 1Israel
Reset all filters
01 1Active
Reset all filters
01 1Complete
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2014-08-20
Pay. Date : 2014-04-22
DMF Number : 28182
Submission : 2014-05-18
Status : Active
Type : II
20
Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
One of their notable products is IMATINIB MESYLATE FORM ALPHA, with a corresponding US DMF Number 28182.
Remarkably, this DMF maintains an Active status since its submission on May 18, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2014, and payment made on April 22, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II